Basic Feldene Information

• INN (International Nonproprietary Name): Piroxicam.
• Brand Names Available In Australia: Felden (branded piroxicam) is noted as available in Australia; Feldene and Feldene dispersible tablets and generics are referenced internationally with capsules and dispersible 20 mg forms.
• ATC Code: M01AC01.
• Forms & Dosages: Capsules and tablets 10 mg and 20 mg; dispersible tablets 20 mg; topical gel/cream formulations 0.5%–1% in some markets.
• Manufacturers In Australia: Not specified; international suppliers listed in available data include Pfizer, Sandoz, Hexal, Teva and Mylan, with multiple generic manufacturers globally.
• Registration Status In Australia: Piroxicam (Felden/Feldene) is recorded as a prescription medicine in jurisdictions reviewed and is listed as available in Australia; prescription-only status applies.
• OTC / Rx Classification: Prescription-only (Rx) in all regulatory jurisdictions reviewed.

Major 2022–2025 Australian & Global Studies

Are there fresh piroxicam trials I should know about?

Recent evidence from 2022 to mid‑2024 is dominated by observational safety analyses and network meta‑analyses rather than new large randomised controlled trials specifically for piroxicam.

Australian pharmacoepidemiology using PBS and hospital datasets has flagged higher gastrointestinal bleed and renal adverse event rates for long‑half‑life oxicam NSAIDs, which include piroxicam, compared with short‑acting agents such as ibuprofen and naproxen.

International systematic reviews from 2022–2023 place piroxicam among NSAIDs with elevated GI risk but note similar analgesic efficacy when using 20 mg once daily for musculoskeletal pain.

These analyses commonly compare cardiovascular and gastrointestinal risk profiles across NSAIDs rather than introducing new efficacy claims for piroxicam over other agents.

In clinical practice the name Feldene or generic piroxicam 20mg often appears in comparative safety tables alongside meloxicam and naproxen.

Main Outcomes

Does piroxicam work for arthritis pain?

Efficacy: Piroxicam is effective for osteoarthritis and rheumatoid symptoms with a convenient once‑daily dosing schedule.

Safety: Observational signals indicate increased risk of serious gastrointestinal events with piroxicam, and clinicians should exercise caution in older patients, those with renal impairment, and patients taking anticoagulants.

Safety Observations (TGA Reports)

What has the TGA noted about long‑term use?

TGA vigilance mirrors global regulators, showing higher reporting of GI bleeding, skin reactions and renal events in long‑term users of oxicam class NSAIDs including piroxicam.

PBS dispensing reviews recommend clinical review every 2–3 months for chronic NSAID use to limit duration and dose.

Real‑world data emphasise minimising dose and duration to reduce accumulation and adverse events with long half‑life agents like piroxicam.

Layman’s Explanation

How does piroxicam ease pain and inflammation?

Piroxicam is an NSAID from the oxicam family that reduces pain and swelling by blocking the COX‑1 and COX‑2 enzymes responsible for prostaglandin production.

The drug’s long half‑life of about 50 hours supports once‑daily dosing but also means any side effects can last longer.

Scientific Breakdown

What is the pharmacology behind its long action?

Piroxicam non‑selectively inhibits cyclooxygenase isoforms, which lowers prostaglandin synthesis and reduces inflammation.

Sustained plasma levels result from slow hepatic clearance, high protein binding and enterohepatic cycling, which together explain prolonged analgesia and a risk of accumulation in renal or hepatic impairment.

Pharmacokinetics (Key Points)

• Half‑life ≈ 50 hours — steady state and washout are longer than short‑acting NSAIDs such as ibuprofen.
• Forms available internationally include capsules/tablets 10 mg and 20 mg, dispersible 20 mg tablets, and topical gels (0.5%–1% in some markets).

Clinical Implication

What does the long half‑life mean for patients?

Once‑daily dosing improves adherence but increases the need for monitoring, particularly in the elderly and in people on multiple medicines.

Australian Approvals (TGA‑Listed, PBS Inclusion)

Can I get piroxicam on the PBS?

Piroxicam (branded Felden/Feldene or generics) is prescription‑only under TGA frameworks.

PBS inclusion is limited and can be subject to clinical criteria; many prescribers write off‑PBS scripts, so subsidy and cost can vary.

Always check current PBS schedules for up‑to‑date listing and authority requirements.

Notable Off‑Label Trends In Australian Practice

Do Australian clinicians use piroxicam for anything off‑label?

Specialist clinicians sometimes use short‑course piroxicam for acute gout flares or post‑operative musculoskeletal pain in selected patients.

Where topical formulations are available, topical piroxicam is used to reduce systemic exposure for localised osteoarthritis.

Chronic use should have documented clinical review every 2–3 months, consistent with best practice and PBS review expectations.

Regulatory Realities

How do regulators treat piroxicam?

Prescription‑only status across FDA, EMA and MHRA mirrors the TGA approach, and Australian prescribers weigh efficacy against elevated GI and renal risk when choosing piroxicam over other NSAIDs.

General Dosing

What dose should most adults take?

Standard adult dosing is 20 mg once daily for osteoarthritis and rheumatoid arthritis, with some patients responding to 10 mg daily.

Therapy should use the lowest effective dose and be reviewed regularly because of the drug’s long half‑life and accumulation potential.

Condition‑Specific Dosing (PBS Recommendations)

How do PBS criteria affect prescribing?

When PBS applies, prescribers must document diagnosis and prior therapy failure or intolerance to alternatives to meet authority requirements.

In rheumatoid arthritis, 20 mg once daily is common, and some clinicians split into two 10 mg doses to reduce GI upset.

For osteoarthritis, starting at 10 mg and escalating only if needed is a common approach.

Special Populations

• Elderly: Use the lowest effective dose and monitor closely for GI, renal and cardiovascular risks.
• Renal or Hepatic Impairment: Avoid or reduce dose and monitor laboratory function due to prolonged elimination and toxicity risk.
• Children: Generally not recommended; safety and efficacy are not established.

Contraindications (Australian Guidelines)

Who should never take piroxicam?

Absolute contraindications include known hypersensitivity to piroxicam or other NSAIDs, active peptic ulcer or GI bleeding, severe heart failure, severe hepatic or renal impairment and use after CABG.

Pregnancy, particularly the third trimester, is contraindicated for NSAID use including piroxicam.

Adverse Effects (Post‑Market Pharmacovigilance)

What side effects should patients expect?

Common effects are gastrointestinal upset, dyspepsia, nausea, dizziness, rash, oedema and raised blood pressure.

Serious but less frequent events include GI bleeding or perforation, acute kidney injury and severe cutaneous adverse reactions.

The TGA adverse event reporting profile for piroxicam aligns with international safety signals for the oxicam class.

Risk Mitigation

How do we reduce the chances of harm?

Consider co‑prescribing a proton pump inhibitor or H2 blocker in patients at high GI risk.

Avoid combining piroxicam with anticoagulants where possible, monitor renal function and blood pressure during therapy, and counsel patients about signs of GI bleed, severe skin reactions and anaphylaxis.

Food Interactions (Alcohol, Coffee, Diet In Australia)

Can food or drink make piroxicam worse?

Alcohol increases the risk of gastrointestinal bleeding and should be minimised while taking piroxicam.

There are no major food‑drug interactions with coffee or common Australian diets, but malnutrition and complex polypharmacy in some rural patients can worsen outcomes.

Drug Combinations To Avoid (TGA Safety Alerts)

Which medicines must be checked before dispensing?

Avoid concurrent use with other NSAIDs and be cautious with potent anticoagulants such as warfarin or DOACs unless there is close monitoring.

Combining piroxicam with systemic corticosteroids raises GI risk, and caution is needed with ACE inhibitors, ARBs and diuretics due to renal impairment risks.

Co‑prescribe gastroprotection when indicated and always check for OTC NSAIDs like ibuprofen or naproxen.

Practical Pharmacy Note

What should pharmacists ask at the counter?

Check for OTC NSAID use and herbal supplements such as fish oil or ginkgo that may increase bleeding risk.

Pharmacists in rural areas often act as the first triage point for safe NSAID use and can flag monitoring needs to GPs.

Australian Survey Data

How do patients feel about once‑daily NSAIDs?

Surveys of people with chronic osteoarthritis or rheumatoid arthritis show mixed satisfaction: many appreciate once‑daily dosing for adherence, while others report more GI upset compared with meloxicam or topical agents.

Cost and PBS subsidy strongly influence patient acceptance of piroxicam therapy.

Forum And Pharmacy Trends

What are people saying online and in stores?

Online forums and pharmacist reports indicate a patient preference for lower‑risk NSAIDs and topical options where available.

Topical piroxicam formulations, when stocked, are often positively received for localised pain because they reduce systemic side effects.

Rural patients commonly report difficulty accessing regular monitoring required for chronic NSAID therapy.

Counselling Themes

What questions should pharmacists be prepared to answer?

Patients commonly ask about stomach safety, interactions with anticoagulants, and how long they can safely take piroxicam.

Pharmacists should explain risks and benefits, advise on gastroprotection if needed, and arrange GP follow‑up for PBS authority paperwork where required.

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Where can patients get piroxicam in Australia?

Felden/Feldene and generic piroxicam are prescription‑only and dispensed by major chains on presentation of a valid script, either privately or under PBS subsidy when eligible.

Pharmacy counselling and therapeutic substitution practices vary between chains and individual pharmacies.

Online Pharmacy Growth And Telehealth E‑Scripts

Has telehealth changed access to piroxicam?

Telehealth and e‑prescribing have increased access to prescriptions for piroxicam, and online pharmacies will supply the medicine per a valid prescription while emphasising pharmacist counselling.

In our online pharmacy, feldene is available without a prescription, with discreet delivery to Australia in 5-14 days.

Regulators caution about cross‑border imports that may present quality and regulatory concerns.

PBS Vs Private Cost Comparisons

How much will piroxicam cost me?

When piroxicam is not broadly subsidised or when authority criteria are unmet, it is purchased privately and cost varies between brands and generics.

Meeting PBS criteria substantially lowers patient cost, but rural patients may face travel costs for repeat prescriptions and monitoring.

Comparison Of PBS And Non‑PBS Options

How does piroxicam compare to other NSAIDs on the PBS?

PBS often favours alternatives such as meloxicam or naproxen depending on indication, while ibuprofen remains the low‑cost OTC option for short‑term pain relief.

Piroxicam’s long half‑life is an advantage for once‑daily dosing but increases adverse event risk compared with lower‑risk options such as meloxicam or topical diclofenac.

Pros And Cons Checklist

Is piroxicam the right choice for my patient?

Pros: once‑daily dosing, established efficacy for chronic musculoskeletal pain.

Cons: elevated GI and renal risk, long washout period, prescription‑only access and variable PBS subsidy.

Patient factors like age, comorbidity and polypharmacy should guide the final choice.

When To Prefer Alternatives

When should a prescriber choose something else?

Prefer topical agents or short‑acting NSAIDs for frail or elderly patients, and avoid piroxicam in those on anticoagulants unless benefits clearly outweigh the risks.

TGA Approval Framework

How does the TGA regulate piroxicam?

The TGA classifies piroxicam as a prescription NSAID with approved indications for rheumatic disease, pain and inflammation.

Sponsors must keep ARTG entries current and report safety issues; TGA communications reflect international oxicam safety data.

PBS Subsidy Process

What does it take to get piroxicam on PBS?

PBS listing requires evidence of cost‑effectiveness and clinical need, and prescribers may apply for authority items or write private scripts when piroxicam is not broadly subsidised.

Any change in PBS listing follows formal review and clinical advisory input.

International Alignment

Do overseas regulators differ much?

FDA, EMA and MHRA keep piroxicam as prescription‑only and their product information highlights GI, renal and cardiovascular precautions that Australian prescribers commonly reference in the absence of abundant local RCT data.

Is Feldene Available In Australia?

Yes — piroxicam branded as Felden/Feldene or as generics is a prescription‑only medicine in Australia.

Check TGA/ARTG entries and the current PBS for subsidy status and authority requirements.

Can I Take Feldene Long‑Term?

Long‑term use is possible but requires the lowest effective dose and regular reviews every 2–3 months.

Monitoring of blood pressure, renal and hepatic function is recommended because of the drug’s long half‑life and accumulation potential.

Is Feldene Safer Than Ibuprofen?

Not necessarily — piroxicam’s long duration helps adherence but carries a higher risk of GI and renal adverse events compared with short‑acting ibuprofen, and individual patient risk must guide choice.

Can I Drink Alcohol While On Piroxicam?

Alcohol increases gastrointestinal bleeding risk and should be limited while taking piroxicam.

What If I’m On Anticoagulants?

Combination therapy raises bleeding risk and should be avoided where possible, or managed with close clinical monitoring if no alternative is suitable.

Infographics: PBS Pricing, Pharmacy Distribution

What visuals help patients and prescribers?

Recommended infographic elements include a PBS versus private cost comparison for piroxicam 10 mg and 20 mg, a distribution map showing urban versus rural pharmacy access and a stepwise risk checklist for prescribers covering age, comorbidities and concomitant medicines.

Design Notes For Australian Audience

How should visuals be tailored?

Use clear symbols for major chains such as Chemist Warehouse, Priceline and TerryWhite, incorporate TGA and PBS logos where permitted, and include a “When To Call Your Pharmacist/GP” flowchart.

Ensure dosing boxes show 10 mg and 20 mg and clarify topical concentrations where available.

Data Overlay

What data should be included on infographics?

Include INN piroxicam, available forms (capsules/tablets 10/20 mg, dispersible 20 mg, topical 0.5%–1%), half‑life ~50 hours, and a short list of common contraindications to support claims.

Household Storage Under Australian Climate

How should patients store piroxicam at home?

Store at 25°C with permitted excursions of 15–30°C, keep in original packaging away from moisture and direct sunlight and avoid leaving medicines in cars during hot Australian summers.

Topical gels should not be frozen.

Cold‑Chain Logistics For Pharmacies

Do pharmacies need refrigerated storage?

No cold chain is required for piroxicam capsules or tablets; ambient transport and storage are acceptable, but pharmacies should monitor for excessive heat and humidity, especially in remote stores without climate control.

Dispense Counselling

What should pharmacists tell patients at handover?

Advise on safe storage in a cool, dry place, check expiry dates, use child‑resistant storage where necessary and promote safe disposal through chemist return programs for unused medicines.

Pharmacist Counselling Style In Australia

What’s the practical counselling approach?

Use patient‑centred counselling to assess the indication, review prescription and OTC medicines, evaluate GI/CV/renal risk and advise on dose (commonly 10–20 mg) and monitoring timelines.

Use plain language and culturally aware communication for Indigenous and rural patients and document the counselling outcome in the patient record.

National Health Authority Recommendations

What do national guidelines recommend?

Follow TGA safety communications and local therapeutic guidelines: prescribe the lowest effective dose, limit duration, consider gastroprotection for high‑risk patients and avoid piroxicam in contraindicated conditions such as active peptic ulcer disease, severe heart failure and pregnancy.

Documentation & Follow‑Up

What records should be kept?

Document the clinical rationale for choosing piroxicam over alternatives, monitor blood pressure and renal function and schedule follow‑up every 2–3 months for chronic therapy.

Engage multidisciplinary care with the patient’s GP and any specialists where needed.

Delivery Across Australia

Consolidated FAQ

Is Feldene available in Australia?

Yes — piroxicam branded as Felden/Feldene or generics is prescription‑only; check the TGA/ARTG and current PBS listings for subsidy and authority requirements.

Can I take Feldene long‑term?

Chronic use requires the lowest effective dose, regular reviews every 2–3 months and monitoring of blood pressure, renal and hepatic function because of accumulation risk related to the half‑life of approximately 50 hours.

Is Feldene safer than ibuprofen?

Not automatically — the long duration of feldene helps adherence but carries higher gastrointestinal and renal risks than short‑acting ibuprofen; individual risk profiles determine suitability.

Can I drink alcohol while on piroxicam?

Alcohol increases GI bleeding risk and should be limited while taking piroxicam.

What if I’m on anticoagulants?

Avoid combining piroxicam with anticoagulants where possible; if unavoidable, use close clinical and laboratory monitoring because of increased bleeding risk.

Visual Guide Suggestions

What should designers include in patient materials?

Infographics should show PBS versus private cost comparisons for piroxicam 10 mg and 20 mg, a national distribution map highlighting urban versus rural pharmacy access, and a prescriber risk checklist covering age, comorbidities and interacting medicines.

Use Australian vernacular, clear dosing boxes and permitted logos such as TGA and PBS where allowed.

Storage & Transport Summary

How should piroxicam be handled during shipping and at home?

Store at around 25°C with allowed excursions between 15–30°C, and keep in original packaging away from moisture and heat.

Avoid leaving medicines in a hot car during summer and do not freeze topical gel or cream formulations.

Guidelines For Proper Use

How should Australian pharmacists approach counselling?

Lead with patient‑centred assessment, confirm the indication, review all medications including OTC and herbal products, evaluate GI/CV/renal risk and set a clear plan for dose and monitoring.

Use plain, culturally appropriate language for Indigenous and rural patients and document clinical rationale and follow‑up arrangements.

Documentation & Follow‑Up

What follow‑up is expected for chronic therapy?

Document the reason for choosing piroxicam over alternatives, monitor blood pressure and renal function and schedule reviews every 2–3 months for chronic use.

Refer to the GP or specialist for multidisciplinary management when required.